Bio-Medical Applications Of Connecticut Inc Bristol, CT - 06010

Bio-Medical Applications Of Connecticut Inc is categorized under Kidney Dialysis Centers in Bristol, CT .

Bio-Medical Applications Of Connecticut Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.

If you are seeking more information, feel free to contact Allison Jenks at the company’s branch by writing to 135 Middle St, Bristol, Connecticut CT 06010 or by phoning (860) 584-2155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bio-Medical Applications Of Connecticut Inc
Contact Person: Allison Jenks
Address: 135 Middle St, Bristol, Connecticut 06010
Phone Number: (860) 584-2155
Website Address: ctnurses.org
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 621492
Share This Business:

Bio-Medical Applications Of Connecticut Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Allison Jenks for inquiries that concern Bio-Medical Applications Of Connecticut Inc by calling the company number (860) 584-2155, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Connecticut Inc can be found at the coordinates 41.665613,-72.921299 as well as the street address 135 Middle St in Bristol, Connecticut 06010.

For its online presence, you may visit Bio-Medical Applications Of Connecticut Inc’s website at ctnurses.org and engage with its social media outlets through on Twitter and on Facebook.